Finally, we demonstrated that overexpression of GSK3β dramatically suppressed tumor growth, angiogenesis, EMT, and the expression of β‐catenin and MYH9 in animal models generated by SAMD9 overexpressing ESCC cells (Figure 6h). Here, GSK3B is linked to esophageal squamous cell carcinoma.